{
    "organizations": [],
    "uuid": "1bb5579a0aec6aaf2cb0d12519826b3bb4b26fa7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-imprimis-pharmaceuticals-q4-revenu/brief-imprimis-pharmaceuticals-q4-revenue-7-3-million-idUSASB0C9JA",
    "ord_in_thread": 0,
    "title": "BRIEF-Imprimis Pharmaceuticals Q4 Revenue $7.3 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Imprimis Pharmaceuticals Inc:\n* IMPRIMIS PHARMACEUTICALS ANNOUNCES FOURTH QUARTER 2017 RESULTS\n* Q4 REVENUE ROSE 27 PERCENT TO $7.3 MILLION Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-09T05:19:00.000+02:00",
    "crawled": "2018-03-09T14:13:42.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "imprimis",
        "pharmaceutical",
        "inc",
        "imprimis",
        "pharmaceutical",
        "announces",
        "fourth",
        "quarter",
        "result",
        "q4",
        "revenue",
        "rose",
        "percent",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}